Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;24(1):30-48.
doi: 10.1016/j.molmed.2017.11.005. Epub 2017 Dec 12.

Metabolic Control of CD8 + T Cell Fate Decisions and Antitumor Immunity


Metabolic Control of CD8 + T Cell Fate Decisions and Antitumor Immunity

Lianjun Zhang et al. Trends Mol Med. .


CD8+ T cells are central players in controlling infections and cancer. Longevity, functionality, and metabolic fitness are critical determinants of T cell efficacy in cancer immunotherapy. Tumor-infiltrating CD8+ T cells undergo metabolic 'exhaustion' in the nutrient- and oxygen-deprived tumor microenvironment (TME). Thus, reprograming CD8+ T cell metabolism may provide important therapeutic strategies for cancer treatment. Indeed, the adoptive transfer of memory CD8+ T cells with sustained metabolic fitness may yield better antitumor protection in both mouse models and the clinic. Here, we discuss recent progress on how cellular metabolism is linked to CD8+ T cell fate decisions and on how metabolic intermediates can impact gene expression via modulation of the epigenome. We examine the feasibility of developing potential strategies to improve antitumor immunity through the modulation of T cell metabolic activity.

Similar articles

See all similar articles

Cited by 16 articles

See all "Cited by" articles

Publication types


LinkOut - more resources